- Home
- TNGX vs BRT Comparison
TNGX vs BRT Comparison
Compare TNGX & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- BRT
- Stock Information
- Founded
- TNGX 2014
- BRT 1972
- Country
- TNGX United States
- BRT United States
- Employees
- TNGX N/A
- BRT N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- BRT Real Estate Investment Trusts
- Sector
- TNGX Health Care
- BRT Real Estate
- Exchange
- TNGX Nasdaq
- BRT Nasdaq
- Market Cap
- TNGX 723.2M
- BRT 288.5M
- IPO Year
- TNGX N/A
- BRT N/A
- Fundamental
- Price
- TNGX $6.82
- BRT $16.33
- Analyst Decision
- TNGX Strong Buy
- BRT Strong Buy
- Analyst Count
- TNGX 6
- BRT 1
- Target Price
- TNGX $10.00
- BRT $21.00
- AVG Volume (30 Days)
- TNGX 1.5M
- BRT 24.3K
- Earning Date
- TNGX 11-05-2025
- BRT 11-06-2025
- Dividend Yield
- TNGX N/A
- BRT 6.20%
- EPS Growth
- TNGX N/A
- BRT N/A
- EPS
- TNGX N/A
- BRT N/A
- Revenue
- TNGX $24,296,000.00
- BRT $98,407,000.00
- Revenue This Year
- TNGX $6.56
- BRT N/A
- Revenue Next Year
- TNGX N/A
- BRT $4.51
- P/E Ratio
- TNGX N/A
- BRT N/A
- Revenue Growth
- TNGX N/A
- BRT 2.46
- 52 Week Low
- TNGX $1.03
- BRT $14.17
- 52 Week High
- TNGX $10.81
- BRT $20.22
- Technical
- Relative Strength Index (RSI)
- TNGX 52.79
- BRT 61.22
- Support Level
- TNGX $6.25
- BRT $16.01
- Resistance Level
- TNGX $6.90
- BRT $16.51
- Average True Range (ATR)
- TNGX 0.41
- BRT 0.39
- MACD
- TNGX -0.04
- BRT 0.06
- Stochastic Oscillator
- TNGX 49.57
- BRT 83.78
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.